Leukemia Clinical Trials in North Carolina

Showing 1421-1440 of 1,759 trials

Recruiting African American Fathers/ Sons

NCT02811848

The purpose of this study is to develop and pilot test recruitment methods for a future study of prevention of sexually transmitted infections (STI), including the human immunodeficiency virus (HIV), among Black adolescent boys through sexual health education by their fathers.

Sexually Transmitted DiseasesHIV

Duke University28 participantsStarted May 2016

Greensboro, North Carolina, United States

COMPLETEDNA36 miles

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

NCT00417040

This pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and Leukemia Group B (CALGB) studies. A study that evaluates a patient's ability to use a clinic waiting room computer to report their symptoms and their ability to carry out daily activities may help doctors understand a patient's use of a computer to report symptoms.

Prostate CancerBreast CancerLung Cancer+3 more

Alliance for Clinical Trials in Oncology325 participantsStarted Dec 2006

Castro Valley, California, United States • Castro Valley, California, United States • Fremont, California, United States +92 more locations

Recruiting African American Fathers/ Sons

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Leukemia Trials in Other Cities

A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia

Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

Early Blood Pressure Management in Extremely Premature Infants

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

CNDO-109-AANK for AML in First Complete Remission (CR1)

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Other Conditions in North Carolina